Blood biomarkers forecast long-term blood pressure improvement after adolescent bariatric surgery

Blood biomarkers forecast long-term blood pressure improvement after adolescent bariatric surgery

A groundbreaking study published in Hypertension, the journal of the American Heart Association, has identified a set of blood-based biomarkers that can predict improvements in blood pressure five years after adolescents underwent metabolic bariatric surgery. This is the first study to demonstrate that measures of a patient’s unique biological profile taken before weight loss surgery…

Read More
Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings

Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings

DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link

Read More
Findings from Latest DAa-ViNCI Study

Findings from Latest DAa-ViNCI Study

Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link

Read More
Continuing ACE Inhibitors and ARBs Before Non-Cardiac Surgery Linked to Lower Postoperative Mortality and Functional Decline: Study

Continuing ACE Inhibitors and ARBs Before Non-Cardiac Surgery Linked to Lower Postoperative Mortality and Functional Decline: Study

Continuing ACE Inhibitors and ARBs Before Non-Cardiac Surgery Linked to Lower Postoperative Mortality and Functional Decline: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link

Read More